DK1280812T3 - Cyclipostiner, fremgangsmåde til deres fremstilling og anvendelse af samme - Google Patents

Cyclipostiner, fremgangsmåde til deres fremstilling og anvendelse af samme

Info

Publication number
DK1280812T3
DK1280812T3 DK01936275T DK01936275T DK1280812T3 DK 1280812 T3 DK1280812 T3 DK 1280812T3 DK 01936275 T DK01936275 T DK 01936275T DK 01936275 T DK01936275 T DK 01936275T DK 1280812 T3 DK1280812 T3 DK 1280812T3
Authority
DK
Denmark
Prior art keywords
cyclipostins
physiologically compatible
preparation
compounds
same
Prior art date
Application number
DK01936275T
Other languages
English (en)
Inventor
Laszlo Vertesy
Klaus Ehrlich
Michael Kurz
Joachim Wink
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1280812T3 publication Critical patent/DK1280812T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65744Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01936275T 2000-05-04 2001-04-25 Cyclipostiner, fremgangsmåde til deres fremstilling og anvendelse af samme DK1280812T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10021731A DE10021731B4 (de) 2000-05-04 2000-05-04 Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben
PCT/EP2001/004652 WO2001083497A1 (de) 2000-05-04 2001-04-25 Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben

Publications (1)

Publication Number Publication Date
DK1280812T3 true DK1280812T3 (da) 2005-05-30

Family

ID=7640768

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01936275T DK1280812T3 (da) 2000-05-04 2001-04-25 Cyclipostiner, fremgangsmåde til deres fremstilling og anvendelse af samme

Country Status (28)

Country Link
EP (1) EP1280812B1 (da)
JP (1) JP5038572B2 (da)
KR (1) KR100779867B1 (da)
CN (1) CN1216890C (da)
AR (1) AR028398A1 (da)
AT (1) ATE288442T1 (da)
AU (2) AU2001262229B2 (da)
BR (1) BR0110459A (da)
CA (1) CA2407808C (da)
CZ (1) CZ20023547A3 (da)
DE (2) DE10021731B4 (da)
DK (1) DK1280812T3 (da)
EE (1) EE05090B1 (da)
ES (1) ES2236234T3 (da)
HK (1) HK1055745A1 (da)
HR (1) HRP20020864A2 (da)
HU (1) HUP0300306A3 (da)
IL (2) IL152612A0 (da)
MX (1) MXPA02010297A (da)
NO (1) NO330438B1 (da)
NZ (1) NZ522352A (da)
PL (1) PL358328A1 (da)
PT (1) PT1280812E (da)
RU (1) RU2266911C2 (da)
SK (1) SK15602002A3 (da)
WO (1) WO2001083497A1 (da)
YU (1) YU81502A (da)
ZA (1) ZA200208928B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4870569B2 (ja) 2003-11-13 2012-02-08 ハンミ ホールディングス カンパニー リミテッド 免疫グロブリン断片を用いた蛋白質結合体およびその製造方法
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
KR100754667B1 (ko) 2005-04-08 2007-09-03 한미약품 주식회사 비펩타이드성 중합체로 개질된 면역글로불린 Fc 단편 및이를 포함하는 약제학적 조성물
EP1894601A1 (en) 2006-08-29 2008-03-05 sanofi-aventis Treating mycobacterial infections with cyclipostins
KR200453850Y1 (ko) * 2008-04-23 2011-05-30 주식회사 에이티티알앤디 수질 관리 센서 내장형 수도미터기
KR102073748B1 (ko) 2013-01-31 2020-02-05 한미약품 주식회사 재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
AR096891A1 (es) 2013-07-12 2016-02-03 Hanmi Pharm Ind Co Ltd Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04145089A (ja) * 1990-10-05 1992-05-19 Nippon Kayaku Co Ltd 抗生物質nk901093、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
JPH0656859A (ja) * 1991-07-25 1994-03-01 Nippon Kayaku Co Ltd 抗生物質nk901093a、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤

Also Published As

Publication number Publication date
HK1055745A1 (en) 2004-01-21
NO20025209L (no) 2002-10-30
ZA200208928B (en) 2003-10-07
BR0110459A (pt) 2003-03-11
CA2407808C (en) 2013-06-25
CA2407808A1 (en) 2002-10-30
HUP0300306A3 (en) 2004-10-28
CZ20023547A3 (cs) 2003-02-12
IL152612A (en) 2009-11-18
AR028398A1 (es) 2003-05-07
JP5038572B2 (ja) 2012-10-03
NZ522352A (en) 2004-06-25
EE05090B1 (et) 2008-10-15
NO20025209D0 (no) 2002-10-30
MXPA02010297A (es) 2003-04-25
YU81502A (sh) 2006-05-25
PT1280812E (pt) 2005-05-31
NO330438B1 (no) 2011-04-11
AU2001262229B2 (en) 2007-01-25
AU6222901A (en) 2001-11-12
CN1427845A (zh) 2003-07-02
JP2003531914A (ja) 2003-10-28
DE10021731A1 (de) 2001-11-15
HRP20020864A2 (en) 2004-12-31
EP1280812A1 (de) 2003-02-05
SK15602002A3 (sk) 2003-04-01
WO2001083497A1 (de) 2001-11-08
KR20030009464A (ko) 2003-01-29
CN1216890C (zh) 2005-08-31
ATE288442T1 (de) 2005-02-15
IL152612A0 (en) 2003-06-24
EE200200599A (et) 2004-04-15
DE10021731B4 (de) 2005-12-08
ES2236234T3 (es) 2005-07-16
DE50105249D1 (de) 2005-03-10
KR100779867B1 (ko) 2007-11-27
EP1280812B1 (de) 2005-02-02
HUP0300306A2 (hu) 2003-06-28
PL358328A1 (en) 2004-08-09
RU2266911C2 (ru) 2005-12-27

Similar Documents

Publication Publication Date Title
SE0200920D0 (sv) Novel compounds
ATE316083T1 (de) Adamantanderivate
SE0103836D0 (sv) Novel compounds
BR0212871A (pt) Concentrado fomador de microemulsão, microemulsão e métodos de aplicar uma composição herbicida e um herbicida e de preparar um concentrado formador de microemulsão e uma microemulsão
BR0316375A (pt) Diazinopirimidinas
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
NO20024772L (no) Percyquinnin, fremgangsmÕte for dets fremstilling og dets anvendelse som et legemiddel
SE0202539D0 (sv) Compounds
SE0300480D0 (sv) Novel compounds
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
SE9901875D0 (sv) Novel compounds
SE0302192D0 (sv) Novel compounds
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
ATE300541T1 (de) Pyrazolopyridinderivate
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
BR0213066A (pt) Compostos de cianoacetila
SE0101038D0 (sv) Novel compounds
DK1280812T3 (da) Cyclipostiner, fremgangsmåde til deres fremstilling og anvendelse af samme
MXPA04004621A (es) Nucleotidos, preparaciones de los mismos y su utilizacion como inhibidores de polimerasas virales de arn.
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
SE0202693D0 (sv) Compounds
SE0102057D0 (sv) New Salts I
SE0202692D0 (sv) Compounds